Abstract
Interest in the effectiveness of psychological interventions in patients with psychosis has increased in the last 2 decades, and early intervention programs are increasingly common. PIENSA (Programa de Intervención en Psicosis Adolescente; Intervention Program for Adolescent Psychosis) is a clinical program and pilot study based on previous research into the efficacy of early intervention in preventing relapse and improving outcome in patients with first-episode psychosis.
We describe a psychoeducational intervention designed for adolescents with early-onset psychosis and their parents. The intervention is adapted from McFarlane’s Multiple Family Therapy model to our setting and population (adolescents treated in the Spanish public health system). It consists of 2 stages: an individual stage comprising 3 sessions and a subsequent group stage comprising 12 sessions. The total program lasts for 1 academic year (9 months).
We present the design of our program and our preliminary experience in a Child and Adolescent Unit in Spain.
Keywords: Adolescents, family intervention, group therapy, psychoeducational, psychosis, treatment.
Adolescent Psychiatry
Title:PIENSA: Development of an Early Intervention Program for Adolescents With Early-Onset Psychosis and Their Families
Volume: 2 Issue: 3
Author(s): Ana Ruiz-Sancho, Ana Calvo, Marta Rapado-Castro, Miguel Moreno, Carmen Moreno, Teresa Sanchez-Gutierrez, Cecilia Tapia, Guadalupe Chiclana, Pamela Rodriguez, Patricia Fernandez, Celso Arango and Maria Mayoral
Affiliation:
Keywords: Adolescents, family intervention, group therapy, psychoeducational, psychosis, treatment.
Abstract: Interest in the effectiveness of psychological interventions in patients with psychosis has increased in the last 2 decades, and early intervention programs are increasingly common. PIENSA (Programa de Intervención en Psicosis Adolescente; Intervention Program for Adolescent Psychosis) is a clinical program and pilot study based on previous research into the efficacy of early intervention in preventing relapse and improving outcome in patients with first-episode psychosis.
We describe a psychoeducational intervention designed for adolescents with early-onset psychosis and their parents. The intervention is adapted from McFarlane’s Multiple Family Therapy model to our setting and population (adolescents treated in the Spanish public health system). It consists of 2 stages: an individual stage comprising 3 sessions and a subsequent group stage comprising 12 sessions. The total program lasts for 1 academic year (9 months).
We present the design of our program and our preliminary experience in a Child and Adolescent Unit in Spain.
Export Options
About this article
Cite this article as:
Ruiz-Sancho Ana, Calvo Ana, Rapado-Castro Marta, Moreno Miguel, Moreno Carmen, Sanchez-Gutierrez Teresa, Tapia Cecilia, Chiclana Guadalupe, Rodriguez Pamela, Fernandez Patricia, Arango Celso and Mayoral Maria, PIENSA: Development of an Early Intervention Program for Adolescents With Early-Onset Psychosis and Their Families, Adolescent Psychiatry 2012; 2 (3) . https://dx.doi.org/10.2174/2210676611202030229
DOI https://dx.doi.org/10.2174/2210676611202030229 |
Print ISSN 2210-6766 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6774 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cyclin-Dependent Kinase Inhibitors: Cancer Killers to Neuronal Guardians
Current Medicinal Chemistry Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain
CNS & Neurological Disorders - Drug Targets Drugs Made of RNA: Development and Application of Engineered RNAs for Gene Therapy
Mini-Reviews in Medicinal Chemistry Editorial [Hot Topic:Neurodegenerative Disorders: From Molecules to Man (Part 1) (Guest Editors: Giuseppe Di Giovanni, Vincenzo Di Matteo and Ennio Esposito)]
CNS & Neurological Disorders - Drug Targets Damaged Proteins Bearing L-Isoaspartyl Residues and Aging: A Dynamic Equilibrium Between Generation of Isomerized Forms and Repair by PIMT
Current Aging Science Pathogenesis of and Therapeutic Strategies to Ameliorate the Transthyretin Amyloidoses
Current Pharmaceutical Design The Future of Diabetes Management by Healthy Probiotic Microorganisms
Current Diabetes Reviews Fundamental, Electron Transfer Mechanism by Pyrylium-Type Ions for the Anticancer Drugs 5,6-Dimethylxanthenone-4-Acetic Acid (DMXAA) and Flavone-8-Acetic Acid (FAA)
Current Medicinal Chemistry - Anti-Cancer Agents Leptin as Clinical Target
Recent Patents on Inflammation & Allergy Drug Discovery Considering Autotaxin Inhibitors in Terms of 2D-QSAR and 3D-Mapping- Review and Evaluation
Current Medicinal Chemistry Protein Misfolding in Conformational Disorders: Rescue of Folding Defects and Chemical Chaperoning
Mini-Reviews in Medicinal Chemistry Virtual Screening Against Obesity
Current Medicinal Chemistry A Structural Approach into Human Tryptophan Hydroxylase and its Implications for the Regulation of Serotonin Biosynthesis
Current Medicinal Chemistry Gene Expression Analysis for High Throughput Screening Applications
Combinatorial Chemistry & High Throughput Screening Multi-Faceted Arginine: Mechanism of the Effects of Arginine on Protein
Current Protein & Peptide Science Utilizing Ultrasound to Transiently Increase Blood-Brain Barrier Permeability, Modulate of the Tight Junction Proteins, and Alter Cytoskeletal Structure
Current Neurovascular Research An Efficient Cancer Classification Model for CT/MRI/PET Fused Images
Current Medical Imaging New Anti-Anginal Drugs: Ranolazine
Cardiovascular & Hematological Agents in Medicinal Chemistry Mitochondrial Disturbances, Tryptophan Metabolites and Neurodegeneration: Medicinal Chemistry Aspects
Current Medicinal Chemistry Nano-Neurotherapeutics (NNTs): An Emergent and Multifaceted Tool for CNS Disorders
Current Drug Metabolism